Clinical Guest Contributors

  1. An FDA First: Dompé Shares Experience Of Securing A Commissioner's National Priority Voucher 11/25/2025

    Dompé Chief Development Officer Ahmed Enayetallah reveals how the team earned the FDA's new Commissioner’s National Priority Voucher.

  2. A Tale Of Two Sites: How FastWave Ran Trials In Distinct Locales 11/24/2025

    No two sites are the same. Discover how FastWave Medical chose its global sites, and learn best practices on who to partner with and how.

  3. Why Site Relationships With Sponsors and CROs Must Evolve Now 11/24/2025

    Sites are central to drug development — we cannot run a trial without them — yet the industry continues to treat them as tactical, temporary instruments. It’s time to break this cycle, implores Jim Kremidas, executive director, Association of Multisite Research Corporations (AMRC).

  4. LinkedIn Message Leads To Advocate-Pharma Pursuit Of Expanded Access 11/21/2025

    Medicus Pharma CEO Raza Bokhari, MD and Gorlin Syndrome Alliance Executive Director Meredith Weiss describe how the two a partnering to match Medicus’ noninvasive treatment for basal cell carcinoma with GSA’s patient community.

  5. Ashvattha Therapeutics Shows Real-World Focus With subQ, Bilateral Dosing For Ophthalmology Drug 11/21/2025

    Ashvattha Therapeutics shows how keeping communication open with the ophthalmic community, investigators, and KOLs can lead to a study balanced by innovation and practicality.

  6. 'ONE In A MILLION' Aims To Bridge The Equity Gap In Clinical Trials 11/20/2025

    Tigerlily Foundation is launching its "ONE in a MILLION" national public-private partnership to engage one million people in high-risk communities with clinical research.

  7. How To Identify Patient-Centric Risks In The TMF With AI And Automation 11/20/2025

    Discover how AI and automation tools transform how we manage TMF content when it comes to identifying patient-centric risks.

  8. How The TMF Demonstrates Patient Safety And Rights In DCTs 11/19/2025

    The TMF is not just a compliance tool, says consultant Donatella Ballerini. It's a window into how well we are protecting patients.

  9. This Real-World Example Illustrates The Power Of Patient Centricity In Clinical Trials 11/19/2025

    Ardelyx Chief Patient Officer Laura Williams, MD, MPH, reflects on how patients with chronic kidney disease (CKD) successfully guided Ardelyx’s clinical trial program.

  10. Begin Your AI-Led Digital Clinical Transformation With A Phased Approach 11/18/2025

    Discover how to establish a holistic AI-led digital strategy, starting with a top-down, phased approach.